Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probing dopamine transporter structure and function by Zn2+-site engineering.

Claus Juul Loland1, Kristine Norgaard-Nielsen, Ulrik Gether

  • 1The Molecular Neuropharmacology Group, Department of Pharmacology, The Panum Institute 18.6, University of Copenhagen, DK-2200 Copenhagen N, Denmark. clausjuul@neuropharm.ku.dk

European Journal of Pharmacology
|November 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synaptojanin1 regulates synaptic dopamine release and axonal integrity via retromer-dependent endosomal sorting.

Research square·2026
Same author

Ultrastructure of dopaminergic varicosities revealed by cryo-correlative light and electron microscopy.

The Journal of cell biology·2026
Same author

Visual attention is linked to temporally structured noradrenaline release in the medial prefrontal cortex.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Brain-wide mapping reveals temporal and sexually dimorphic opioid actions.

Communications biology·2026
Same author

Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and ADHD.

The Journal of clinical investigation·2026
Same author

Computational modelling identifies key determinants of subregion-specific dopamine dynamics in the striatum.

eLife·2026
Same journal

Corrigendum to "Interleukin-4 alleviate polycystic ovary syndrome through promoting the polarization of M2 type macrophages via targeting NF-κB/IκB pathway" [Eur. J. Pharmacol. (2026) 1026 178965].

European journal of pharmacology·2026
Same journal

Hypericin: A potential gut microbiota-based therapeutic for postpartum depression via modulating bile acid metabolism.

European journal of pharmacology·2026
Same journal

Astaxanthin inhibits platelet-mediated thrombosis via suppression of bidirectional αIIbβ3 signaling.

European journal of pharmacology·2026
Same journal

Repurposing of alogliptin to mitigate experimentally-induced ulcerative colitis and its associated pulmonary injury in rats through regulating inflammatory, necroptotic, and ER stress pathways.

European journal of pharmacology·2026
Same journal

Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis.

European journal of pharmacology·2026
Same journal

4-Octyl itaconate attenuates renal calculi formation by inhibiting ferroptosis and oxidative stress via the Nrf2-HO-1/SLC7A11 axis.

European journal of pharmacology·2026
See all related articles

Researchers used Zn2+-binding sites to probe the structure of biogenic amine transporters like the human dopamine transporter (hDAT). This revealed structural constraints and insights into substrate transport mechanisms.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Biogenic amine transporters (DAT, NET, SERT) are crucial targets for psychoactive drugs, including antidepressants and illicit substances.
  • Despite their importance, the detailed structure and substrate translocation mechanisms of these transporters remain poorly understood.

Purpose of the Study:

  • To utilize Zn2+-binding sites as a tool to investigate the structure and function of Na+/Cl--coupled biogenic amine transporters.
  • To specifically focus on the human dopamine transporter (hDAT) to define structural constraints and understand transport mechanisms.

Main Methods:

  • Employing Zn2+-binding sites to probe the tertiary structure of biogenic amine transporters.
  • Analyzing structural data to infer conformational changes during substrate translocation.

Related Experiment Videos

Main Results:

  • Defined the first structural constraints within the tertiary structure of Na+/Cl--coupled biogenic amine transporters.
  • Provided insights into conformational dynamics associated with substrate translocation.
  • Identified critical residues involved in regulating functional states of the transport cycle.

Conclusions:

  • Zn2+-binding sites serve as effective tools for structural and functional studies of biogenic amine transporters.
  • This approach has advanced our understanding of the molecular mechanisms underlying neurotransmitter transport and drug interactions.